Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion type Assertion NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_head.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion wasGeneratedBy ECO_0000218 NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_provenance.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion wasDerivedFrom ctd_human-20150221 NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_provenance.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion SIO_000772 18618250 NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_provenance.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion evidence source_evidence_curated NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_provenance.
- NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_assertion description "[Patients (n = 47) with reactivated hepatitis due to lamivudine-resistant HBV were classified into two groups, with and without potential for progression to hepatic failure, according to the criteria using the data of serum bilirubin level and prothrombin activity after the reactivated hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14172.RAZFD2MSZzhS_zso1Z6vLeFM9rR5GFXvoN0qyHAnG4P3Y130_provenance.